Tomokazu Souma

Tomokazu Souma

Auto-generated profile, based on publicly available information

Tomokazu Souma

Duke University School of Medicine

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TSTomokazu Souma
Tomokazu Souma
STStuart W. Tompson
Stuart W. Tompson
BTBenjamin R. Thomson
Benjamin R. Thomson
OSOwen M Siggs
Owen M Siggs
KKKrishnakumar Kizhatil
Krishnakumar Kizhatil
TYTerri L. Young
Terri L. Young
Primary congenital glaucoma (PCG) is a devastating eye disease and an important cause of childhood blindness worldwide. In PCG, defects in the anterior chamber aqueous humor outflow structures of the eye result in elevated intraocular pressure (IOP); however, the genes and molecular mechanisms involved in the etiology of these defects have not been fully characterized. Previously, we observed PCG-like phenotypes in transgenic mice that lack functional angiopoietin-TEK signaling. Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function. Multiple cellular mechanisms were responsible for the loss of protein function resulting from individual TEK variants, including an absence of normal protein production, protein aggregate formation, enhanced proteasomal degradation, altered subcellular localization, and reduced responsiveness to ligand stimulation. Further, in mice, hemizygosity for Tek led to the formation of severely hypomorphic Schlemm’s canal and trabecular meshwork, as well as elevated IOP, demonstrating that anterior chamber vascular development is sensitive to Tek gene dosage and the resulting decrease in angiopoietin-TEK signaling. Collectively, these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity.

1 February 2017 in Kidney International
Verified
Journal Article
Closed access
MNMasahiro Nezu
Masahiro Nezu
TSTomokazu Souma
Tomokazu Souma
LYLei Yu
Lei Yu
TSTakafumi Suzuki
Takafumi Suzuki
DSDaisuke Saigusa
Daisuke Saigusa
MYMasayuki Yamamoto
Masayuki Yamamoto

6 January 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YYYasuhito Yahara
Yasuhito Yahara
TBTomasa Barrientos
Tomasa Barrientos
YTYuning J. Tang
Yuning J. Tang
VPVijitha Puviindran
Vijitha Puviindran
PNPuviindran Nadesan
Puviindran Nadesan
BABenjamin A. Alman
Benjamin A. Alman

19 July 2021 in eLife
Verified
Journal Article
Open access
SIShintaro Ide
Shintaro Ide
YKYoshihiko Kobayashi
Yoshihiko Kobayashi
KIKana Ide
Kana Ide
SSSarah A Strausser
Sarah A Strausser
KAKoki Abe
Koki Abe
TSTomokazu Souma
Tomokazu Souma
Overwhelming lipid peroxidation induces ferroptotic stress and ferroptosis, a non-apoptotic form of regulated cell death that has been implicated in maladaptive renal repair in mice and humans. Using single-cell transcriptomic and mouse genetic approaches, we show that proximal tubular (PT) cells develop a molecularly distinct, pro-inflammatory state following injury. While these inflammatory PT cells transiently appear after mild injury and return to their original state without inducing fibrosis, after severe injury they accumulate and contribute to persistent inflammation. This transient inflammatory PT state significantly downregulates glutathione metabolism genes, making the cells vulnerable to ferroptotic stress. Genetic induction of high ferroptotic stress in these cells after mild injury leads to the accumulation of the inflammatory PT cells, enhancing inflammation and fibrosis. Our study broadens the roles of ferroptotic stress from being a trigger of regulated cell death to include the promotion and accumulation of proinflammatory cells that underlie maladaptive repair.

23 October 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BTBenjamin R. Thomson
Benjamin R. Thomson
TSTomokazu Souma
Tomokazu Souma
STStuart W. Tompson
Stuart W. Tompson
TOTuncer Onay
Tuncer Onay
KKKrishnakumar Kizhatil
Krishnakumar Kizhatil
SQSusan E. Quaggin
Susan E. Quaggin
Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm’s canal (SC) and the trabecular meshwork. We previously identified loss-of-function mutations in the angiopoietin (ANGPT) receptor TEK in families with PCG and showed that ANGPT/TEK signaling is essential for SC development. Here, we describe roles for the major ANGPT ligands in the development of the aqueous outflow pathway. We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure. By contrast, ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1. In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients. Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease. By linking ANGPT1 with PCG, these results highlight the importance of ANGPT/TEK signaling in glaucoma pathogenesis and identify a candidate target for therapeutic development.

22 January 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TSTomokazu Souma
Tomokazu Souma
BTBenjamin R. Thomson
Benjamin R. Thomson
SHStefan Heinen
Stefan Heinen
ICIsabel Anna Carota
Isabel Anna Carota
SYShinji Yamaguchi
Shinji Yamaguchi
SQSusan E. Quaggin
Susan E. Quaggin
Significance: Reducing vascular leakage and stabilizing the endothelium through activation of the angiopoietin (ANGPT)–TIE2 receptor tyrosine kinase pathway is a promising therapeutic strategy for vascular diseases. ANGPT2 is one of two major ligands for the TIE2 receptor. Uniquely, ANGPT2 possesses an agonistic role in lymphatic endothelium, but acts as a competitive antagonist in blood endothelium. The molecular basis for the opposing actions of ANGPT2 in these two vascular beds is poorly understood. Here we demonstrate that the absence of VEPTP expression in the lymphatic endothelium confers an agonist function of ANGPT2 on TIE2 receptor, but VEPTP expression in blood endothelium abrogates its activity. Our findings provide mechanistic insights needed to advance therapeutic targeting of this pathway.